NCT04789668 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT04789668
Title	Bintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain Metastases
Recruitment	Completed
Gender	both
Phase	Phase Ib/II
Variant Requirements	No
Sponsors	M.D. Anderson Cancer Center
Indications	triple-receptor negative breast cancer Advanced Solid Tumor melanoma lung non-small cell carcinoma estrogen-receptor positive breast cancer progesterone-receptor positive breast cancer
Therapies	Bintrafusp alfa + Pimasertib
Age Groups:	adult \| senior
Covered Countries	USA

Facility	Status	City	State	Zip	Country	Details
M D Anderson Cancer Center		Houston	Texas	77030	United States	Details

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT04789668Clinical Trial Detail